Pentixapharm Holding AG
Develops radiopharmaceuticals for diagnosing and treating oncology and adrenal disorders.
PTP | F
Overview
Corporate Details
- ISIN(s):
- DE000A383RV0 (+1 more)
- LEI:
- 3912005VBOVXNDXEQZ36
- Country:
- Germany
- Address:
- Robert-Rössle-Straße, 10, 13125 Berlin
- Website:
- https://www.pentixapharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pentixapharm Holding AG is a clinical-stage radiopharmaceutical development company that creates innovative, first-in-class compounds for both diagnostic and therapeutic applications. The company's pipeline primarily targets unmet medical needs in oncology, including hemato-oncology and solid tumors, as well as adrenal disorders. Key assets include two Phase III-ready drug candidates and a well-researched CXCR4-targeting compound. With a strong research and development focus, Pentixapharm has administered its compounds to over 2,000 patients in clinical settings.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-06 11:00 |
Regulatory News Service
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New …
|
English | 10.5 KB | ||
| 2025-09-26 08:00 |
Regulatory News Service
Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acut…
|
English | 11.3 KB | ||
| 2025-09-16 15:19 |
Director's Dealing
Pentixapharm Holding AG: Eckert Wagniskapital und Fruhphasenfinanzierung GmbH, …
|
English | 6.1 KB | ||
| 2025-09-15 11:49 |
Director's Dealing
Pentixapharm Holding AG: Dr. Andreas Eckert, buy
|
English | 5.8 KB | ||
| 2025-08-06 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 723.4 KB | ||
| 2025-07-24 14:04 |
Report Publication Announcement
|
English | 3.9 KB | ||
| 2025-05-27 09:43 |
Regulatory News Service
Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy
|
English | 10.0 KB | ||
| 2025-05-08 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 479.2 KB | ||
| 2025-04-26 16:00 |
Report Publication Announcement
|
English | 3.8 KB | ||
| 2025-04-25 00:00 |
Annual Report
Annual financial report 2024
|
English | 2.3 MB | ||
| 2025-04-24 14:00 |
Regulatory News Service
Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based Pentix…
|
English | 8.8 KB | ||
| 2025-04-17 15:05 |
Pre-Annual General Meeting Information
Pentixapharm Holding AG: Bekanntmachung der Einberufung zur Hauptversammlung am…
|
German | 88.5 KB | ||
| 2025-04-15 08:17 |
Report Publication Announcement
Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guida…
|
English | 6.4 KB | ||
| 2025-03-19 13:20 |
Report Publication Announcement
|
English | 3.9 KB | ||
| 2025-03-18 13:20 |
Report Publication Announcement
|
English | 3.9 KB |
Automate Your Workflow. Get a real-time feed of all Pentixapharm Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pentixapharm Holding AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pentixapharm Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
